Moderna Inc: News

India offered 7.5mn doses of Moderna vaccine under COVAX program

India has been offered 7.5 million doses of Moderna's COVID-19 vaccine through the COVAX global vaccine sharing program, but it is not clear when the jabs will arrive in the country as a consensus on the indemnity clause is yet to be reached, sources said.

04 Jul 2021


Moderna vaccine arriving in India in 2-3 days: Report

Moderna's COVID-19 vaccine is reportedly expected to reach India in the next few days.

29 Jun 2021


Cipla gets DCGI nod to import Moderna COVID-19 vaccine

The Drugs Controller General of India (DCGI) has reportedly allowed the pharmaceutical firm Cipla to import the COVID-19 vaccine developed by US-based biotechnology company Moderna Inc.

16 Jun 2021


Two COVID-19 vaccines for young children show promise in trials

The Moderna COVID-19 vaccine and an experimental protein-based preventive proved to be safe and showed good antibody response against SARS-CoV-2 in a trial on baby rhesus macaques, scientists said.

03 Jun 2021


Most COVID-19 vaccines might offer lasting protection: Study

The world's leading COVID-19 vaccines, including the ones from Pfizer and Moderna, may offer lasting protection that diminishes the need for frequent booster shots.

02 Jun 2021


Foreign COVID-19 vaccines exempted from local trials, batch testing

The Drugs Controller General of India has scrapped the requirement of local trials for foreign-made coronavirus vaccines - a key move to upscale the dwindling COVID-19 vaccinations in the country.

27 May 2021


Pfizer's vaccine works against B.1.617 variant, firm tells Indian government

Pfizer has told the Indian government that its coronavirus vaccine shows "high effectiveness" on the COVID-19 variant prevalent in India as well as on people of Indian ethnicity or nationality.

25 May 2021


India may not receive Pfizer, Moderna vaccine doses until 2023

India may not receive doses of the COVID-19 vaccines developed by Pfizer and Moderna until 2023 as the manufacturers have other commitments.

24 May 2021

Arvind Kejriwal

Pfizer, Moderna have refused to sell vaccines directly to Delhi

American pharmaceutical companies Pfizer and Moderna have said they would not sell their coronavirus vaccines directly to the Delhi government, Chief Minister Arvind Kejriwal revealed today.

14 May 2021


Americans can finally ditch the mask, says CDC

In the biggest indication that the United States is fast returning to pre-pandemic life, the Centers for Disease Control and Prevention (CDC) has said fully vaccinated people are no longer required to wear masks.

13 May 2021


Nawab Malik questions French embassy's procurement of Moderna vaccine

Maharashtra minister Nawab Malik on Thursday claimed that India's French embassy has procured Moderna anti-coronavirus vaccine and it is being administered to its nationals at Navi Mumbai even as only three other vaccines are permitted in India.

30 Mar 2021


Pfizer, Moderna's coronavirus vaccines effective even after first dose: Study

The coronavirus vaccines developed by American pharma giant Pfizer, with Germany's BioNTech, and the one manufactured by Moderna, another United States company, reduce the risk of infection even after the first dose, a study has found, reports Reuters.

01 Mar 2021


AstraZeneca has sold its stake in Moderna for $1 billion

British pharmaceutical company AstraZeneca Plc has sold its 7.7 percent stake in Moderna Inc., the American pharmaceutical giant, for more than $1 billion, according to a report in The Times.

04 Feb 2021


Recovered COVID-19 patients need only one shot of mRNA vaccines

People who have recovered from COVID-19 may need only one shot as opposed to the recommended two jabs if they are taking the Moderna or Pfizer vaccines, according to a study that suggests ways to minimize doses when supplies are limited.

27 Jan 2021


US to purchase additional 200 million coronavirus vaccine doses

US President Joe Biden on Tuesday announced the purchase of additional 200 million doses of coronavirus vaccines as the country reached 25 million COVID-19 infections.

EU agency authorizes Moderna's COVID-19 vaccine

The European Union's medicines agency gave the green light to the Moderna COVID-19 vaccine on Wednesday.

21 Dec 2020


Coronavirus: Myths about the COVID-19 vaccine busted

As vaccines for COVID-19 have started being rolled out in parts of the world, certain myths have been propagated questioning their safety and efficacy.

21 Dec 2020

South Africa

Coronavirus mutation: Here's what we know about the new strain

As the vaccine for COVID-19 had just started rolling out, the worrisome news of the coronavirus mutating has started circulating.

18 Dec 2020

Donald Trump

United States has approved Moderna's COVID-19 vaccine, says Trump

Moderna's COVID-19 vaccine has been approved in the United States, outgoing President Donald Trump announced ahead of the nation's drug regulator.

18 Dec 2020


FDA advisors recommend Emergency Use Authorization of Moderna vaccine

The US Food and Drug Administration's advisory panel, comprising external experts, has given an emergency use approval to Moderna's COVID-19 vaccine, making it the second drug after Pfizer to receive such an authorization in less than a week.

17 Dec 2020

Donald Trump

US angling to secure more of Pfizer's coronavirus vaccine

U.S. officials have said that they are actively negotiating for additional purchases of Pfizer's coronavirus vaccine after they missed the chance to lock in a contract this summer since it was still unclear how well the shots would work.

15 Dec 2020


Moderna vaccine has 'no specific safety concerns,' says US regulator

Moderna's COVID-19 vaccine has been found safe and effective, the United States Food and Drug Administration said in a report on Tuesday.

Moderna says its COVID-19 vaccine '100% effective' against severe cases

United States pharmaceutical company Moderna on Monday said that it will seek emergency approval for its COVID-19 vaccine in the US and Europe.

24 Nov 2020

Oxford University

Russia's Sputnik V at least 91% effective, early data suggests

The Russian vaccine for COVID-19, called Sputnik V, has been found at least 91% effective in the second interim analysis.

18 Nov 2020


Pfizer's COVID-19 vaccine '95% effective'; to seek emergency US authorization

Pharmaceutical giant Pfizer and German drugmaker BioNTech on Wednesday said their COVID-19 vaccine has been found 95% effective in final trials.

11 Nov 2020


US planning Pfizer's coronavirus vaccine distribution as early as December

The United States could begin inoculating its citizens with Pfizer's coronavirus vaccine as early as December, provided the drugmaker submits data from its trial to health regulators, Health Secretary Alex Azar said on Tuesday.

28 Oct 2020

Donald Trump

Coronavirus vaccine in 2020? US drugmaker Pfizer isn't saying no!

Even as experts worldwide have said that an effective coronavirus vaccine won't be out before 2021, American pharma giant Pfizer is hoping to deliver one this year itself, igniting hopes globally.

13 Oct 2020

Johnson & Johnson

Big setback: Johnson & Johnson pauses coronavirus vaccine trial

Pharma giant Johnson & Johnson, which lagged behind its competitors in the coronavirus vaccine race, paused late-stage trials after a volunteer fell sick.

06 Sep 2020


COVID-19 vaccine developers to pledge against rolling out shots prematurely

In light of the havoc wreaked by COVID-19, governments around the world have become more than willing to fast-track regulatory approvals and launch promising vaccines, anti-virals, and tests for their citizens.

04 Sep 2020


#VaccineTracker: Early COVID-19 vaccine results expected by September 15

As the COVID-19 crisis is deteriorating with every passing day, all the hopes are pinned on the development of a safe and effective vaccine.

30 Jul 2020


Coronavirus: How much would the vaccines cost?

As the coronavirus pandemic continues to surge, all hopes rest on the development of a vaccine to beat the virus.

Moderna's COVID-19 vaccine goes into final human trial stage

In a major development, the COVID-19 vaccine developed by biotech giant Moderna Therapeutics has gone into the third and final stage of clinical human trials.

22 Jul 2020


As coronavirus pandemic surges, some vaccine makers expect to profit

Some vaccine makers expect to make profits from their coronavirus vaccines, even as the pandemic continues to rage on.

15 Jul 2020

South Carolina

Moderna's COVID-19 vaccine: Final trials to begin on July 27

Moderna Therapeutics has come a long way with its candidate vaccine to prevent COVID-19, the novel coronavirus disease.

12 Jun 2020


Moderna's COVID-19 vaccine to go into final-stage trials in July

Moderna Therapeutics has announced that its COVID-19 vaccine is set to go into the third and final stage of clinical human trials.

11 Jun 2020

Johnson & Johnson

J&J to begin human trials of COVID-19 vaccine in July

American pharma giant Johnson & Johnson has announced that it will be starting human trials of its experimental COVID-19 vaccine sooner than previously planned.

09 Jun 2020


Moderna's COVID-19 vaccine: When will it be available?

In the race to develop a vaccine for COVID-19, Moderna Therapeutics is seen as one of the fastest-moving players.

22 May 2020


Why the vaccine for COVID-19 is still several months away

In a matter of months, a never-seen-before coronavirus originating from China has turned the whole world upside down.

Moderna's COVID-19 vaccine shows 'positive' results in human trials

Moderna Therapeutics, one of the select few companies working on a COVID-19 vaccine, has revealed positive results from early-stage trials of its formula.

08 May 2020

Oxford University

Moderna's COVID-19 vaccine gets FDA nod for phase 2 trial

Moderna Therapeutics, one of the select few companies trialing a COVID-19 vaccine, has received US Food and Drug Administration's approval to move into the second phase of the tests.